Advances in Neuropathy
FPN Logo
Upgrade   |    Donate Now   |     |   Support Groups  |   Contact Us
August 2016
"Advances in Neuropathy - Emerging Therapies"
FPN Symposium
September 7-9, 2016 The Foundation for Peripheral Neuropathy will be hosting its third biannual international research symposium. We will host more than 70 international scientists, clinical researchers, government and industry leaders focused on peripheral neuropathy research. For more information about what makes the symposium unique among conferences, the symposium's objectives and timeliness, click here!  
What Pain Awareness Groups Can Do For You
FPN Pain Awareness Groups
The Foundation for Peripheral Neuropathy is one of three organizations featured in Pain Pathways magazine serving people and their loved ones dealing with chronic pain. Click here to read the full article. 
Adding Medication Purpose to Prescription Drug Labels Improves Patient Safety
Health professionals, including a pharmacist, at Brigham
Medication Purpose on Labels
and Women's Health call for including the purpose of medications on prescription labels to inform patients and enhance safety, calling it the "sixth" patient right (New England Journal of Medicine, 2016 July 28). "Beyond the 'five rights' for safe medication ordering and use-the right patient, right drug, right dose, right time and right route-a sixth element must be correct: the indication." Providing this information helps create patient engagement in their care. Click here to read more! 
TheraVasc Achieves Major Milestone in Development of Non-addicting and Non-sedating Pain Medication to Treat Diabetic Neuropathy
Development of Non-additcing Pain Med
TheraVasc Inc., headquartered in Cleveland, Ohio, has announced the successful completion of a Phase II clinical study on patients with diabetic neuropathy pain. "Our patients did very well. We noticed statistically significant improvements in the neuropathic pain symptom inventory, which is a standard screening tool for the severity of diabetic neuropathy pain," said Dr. Amol Soin. Click here for more information. 
Commonly Prescribed Medication for Neuropathic Pain May Be Linked to Birth Defects
The drug, pregabalin (Lyrica), commonly used to treat
Commonly Prescribed Medication
pain (including neuropathic pain like diabetic neuropathy), epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Pregnancies of the women who took pregabalin during the first trimester of pregnancy were three times more likely to result in major birth defects than those of the women who did not take anti-seizure drugs. To read more click here!

Like us on Facebook 

Planning on doing some shopping on Amazon? 
May we suggest AmazonSmile instead? 
AmazonSmile is a simple and automatic way for you to support your favorite charitable organization every time you shop, at no cost to you. When you shop at , you'll find the exact same low prices, vast selection and convenient shopping experience as, with the added bonus that Amazon will donate a portion of the purchase price to the Foundation for Peripheral Neuropathy!!! Make sure you type in our organization.  
Looking for more access?  More information? PREMIUM Members of the Foundation for Peripheral Neuropathy get the latest peripheral neuropathy information and exclusive access to valuable resources while supporting the cause.  If you have not yet joined it's easy to do so!
If you're already a member thank you!! 
Click here to Donate!

Disclaimer: The information contained in this e-news is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting a qualified health care provider. You are strongly encouraged to consult a neurologist with any questions or comments you may have regarding your condition. The best care can only be given by a qualified provider who knows you personally.
By clicking "unsubscribe" below, you will no longer receive ANY communication from the Foundation.  If you prefer to stop receiving our
monthly E-News please contact us at to be removed from this list.